Edition:
India

People: Intra-Cellular Therapies Inc (ITCI.OQ)

ITCI.OQ on NASDAQ Stock Exchange Global Select Market

11.78USD
18 Jul 2019
Change (% chg)

-- (--)
Prev Close
$11.78
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
187,996
52-wk High
$23.49
52-wk Low
$10.09

Halstead, Michael 

Mr. Michael I. Halstead is the Executive Vice President, General Counsel and Secretary of Intra-Cellular Therapies, Inc. He has served as Executive Vice President of the Company since January 2019, General Counsel of the Company since July 2014 and Secretary of the Company since September 2014. He also served as Senior Vice President of the Company from July 2014 to December 2018. From July 2005 until December 2013, Mr. Halstead served in a number of leadership positions at Warner Chilcott plc. Most recently he was Senior Vice President, Corporate Development at Warner Chilcott where he directed the company’s corporate development, legal and human resources functions. Prior to that, Mr. Halstead was an attorney at the firm of Davis Polk & Wardwell. Mr. Halstead received his bachelor’s degree from Boston University and his Juris Doctor degree from Villanova University School of Law.

Basic Compensation

Total Annual Compensation, USD 694,100
Restricted Stock Award, USD 749,986
Long-Term Incentive Plans, USD --
All Other, USD 749,110
Fiscal Year Total, USD 2,193,200

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Lawrence Hineline

2,127,810

Michael Halstead

2,193,200

Mark Neumann

--

Andrew Satlin

2,018,330

Robert Davis

2,128,540

John Bardi

--
As Of  31 Dec 2018